A clinical trial has been completed and evaluated whether the alcohol dehydrogenase inhibitor, fomepizole can treat symptoms associated with ALDH2 deficiency (NCT00661141). The gene discussed is ALDH2; the disease is hyperinsulinemic hypoglycemia, familial, 4.